113 related articles for article (PubMed ID: 477028)
1. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
2. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.
Rossen RD; Zubler RH; Day NK; Reisberg MA; Morgan AC; Gutterman JU; Hersh EM
J Lab Clin Med; 1978 Feb; 91(2):191-204. PubMed ID: 413872
[TBL] [Abstract][Full Text] [Related]
3. 125I-C1q binding activity of soluble antigen-antibody complexes formed in vitro.
Soltis RD; Hasz DE
J Clin Lab Immunol; 1982 Nov; 9(2):121-31. PubMed ID: 6984078
[TBL] [Abstract][Full Text] [Related]
4. [Detection of circulating immune complexes by the C1q complement fraction deviation test. 1st application in the study of human glomerulopathies].
Sobel A; Gabay Y; Lagrue G
Nouv Presse Med; 1976 Jun; 5(23):1465-9. PubMed ID: 132639
[TBL] [Abstract][Full Text] [Related]
5. Serial measurement of circulating immune complexes in the sera of patients with leukaemia.
Mód A; Carpentier N; Füst G; Lambert PH; Miescher P; Hollán SR
J Clin Lab Immunol; 1980 Jul; 4(1):15-20. PubMed ID: 7007648
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes and tumor cell cytotoxins as prognostic indicators in malignant melanoma: a prospective study of 53 patients.
Rossen RD; Crane MM; Morgan AC; Giannini EH; Giovanella BC; Stehlin JS; Twomey JJ; Hersh EM
Cancer Res; 1983 Jan; 43(1):422-9. PubMed ID: 6600161
[TBL] [Abstract][Full Text] [Related]
7. C1q-binding substances in peripheral lymph in bronchial carcinoma.
Heier HE; Sokolowski JA; Solheim OP
Lymphology; 1978 Dec; 11(4):170-3. PubMed ID: 739789
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
[TBL] [Abstract][Full Text] [Related]
9. [Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test].
Braun-Falco O; Männel C; Scherer R
Hautarzt; 1977 Dec; 28(12):658-60. PubMed ID: 599025
[TBL] [Abstract][Full Text] [Related]
10. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
11. C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.
Tappeiner G; Heine KG; Kahl JC; Jordon RE
Clin Exp Immunol; 1977 Apr; 28(1):40-8. PubMed ID: 324678
[TBL] [Abstract][Full Text] [Related]
12. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
Casali P; Lambert PH
Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
[TBL] [Abstract][Full Text] [Related]
13. C1q binding activity in the sera of patients with chronic lung diseases.
Cooper KM; Moore M; Hilton AM
Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
[TBL] [Abstract][Full Text] [Related]
14. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
Zubler RH; Lange G; Lambert PH; Miescher PA
J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
[TBL] [Abstract][Full Text] [Related]
15. Immune complexes in scabies. In vitro study of the serum C1q fixation in the presence of mite and unparasited human scale extracts.
Van Neste D; Salmon J
Dermatologica; 1980; 160(2):131-4. PubMed ID: 7351277
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in experimental filariasis.
Karavodin LM; Ash LR
Clin Exp Immunol; 1980 May; 40(2):312-7. PubMed ID: 7438540
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
18. New evidence of circulating immune complexes in Crohn's disease using two sensitive methods.
Pallone F; Montano S; Ricci R; Iavicoli M; Di Mario U
J Clin Lab Immunol; 1981 Jan; 5(1):23-5. PubMed ID: 7218324
[TBL] [Abstract][Full Text] [Related]
19. Immune complexes in patients with drug eruptions: the relationship between skin lesions and circulating immune complexes.
Yanase K; Imamura S
Clin Exp Immunol; 1980 Sep; 41(3):471-7. PubMed ID: 6449338
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
